Case Overview

| | |

|---|---|

| Case Type | TCPA Robocall Class Action |

| Defendant | OptumRx |

| Settlement Amount | $1.8 million |

| Class Size | 155,000+ members |

| Status | Settlement Reached |

OptumRx Agrees to $1.8 Million Settlement in TCPA Robocall Class Action

A pharmacy benefit management company has agreed to pay $1.8 million to resolve allegations that it placed unauthorized robocalls to consumers, according to recent reporting from TCPA World. The settlement, if approved, would cover more than 155,000 class members.

1. OptumRx TCPA Robocall Settlement

Settlement Amount: $1.8 million

Estimated Payout Per Class Member: Approximately $11.60 before fees and costs

Class Size: Over 155,000 individuals

Who May Qualify: Individuals who allegedly received unauthorized robocalls from OptumRx

OptumRx, a subsidiary of UnitedHealth Group that operates as one of the largest pharmacy benefit managers in the United States, has agreed to settle a class action lawsuit alleging violations of the Telephone Consumer Protection Act (TCPA). The complaint alleges that OptumRx placed robocalls to consumers without obtaining the required prior express consent, which the TCPA mandates before companies may contact individuals using automated dialing systems or prerecorded messages.

The proposed settlement covers a class of more than 155,000 people, according to reporting on the case. If the court grants final approval, eligible class members could receive a proportional share of the settlement fund.

How to claim: Check the court docket or settlement administrator's website for claim form details as they become available. Class members who received formal notice should follow the instructions provided in that communication.

What Is the TCPA?

The Telephone Consumer Protection Act is a federal law that restricts how companies may contact consumers by phone. Under the TCPA, businesses generally must obtain prior express written consent before sending automated calls or text messages to a consumer's cell phone. Violations can carry statutory damages of $500 per call, or up to $1,500 per call if a court finds the violation was willful or knowing — which is why TCPA cases, even involving relatively modest individual harm, can accumulate into seven-figure class actions when thousands of consumers are affected.

What the Settlement Means for Class Members

At 155,000 class members sharing a $1.8 million fund, the per-person recovery works out to roughly $11.60 before attorneys' fees and administrative costs are deducted. Individual payouts in TCPA settlements of this scale are often modest — the value of these cases tends to lie in the collective release of claims rather than any single consumer's recovery.

Class members who received a court-approved notice should review it carefully. Those who do not opt out will generally be bound by the settlement's terms and release their TCPA claims against OptumRx, whether or not they submit a claim form.

Key Takeaways

• TCPA settlements don't always require receipts or documentation. In many robocall cases, class members simply need to confirm they received calls during the relevant period — often verifiable through phone records.
• Per-person payouts in large TCPA classes tend to be small. When a class exceeds 100,000 members, individual distributions are frequently in the single digits to low double digits, even in million-dollar settlements.
• Opting out preserves your right to sue individually. If you believe you received a significant number of unauthorized calls, consulting with a TCPA attorney before the opt-out deadline may be worth considering.
• Watch your mail and email for class notices. If you were a customer or contact of OptumRx and received calls during the relevant period, you may already be part of the class.

Have you received robocalls from a pharmacy benefit manager or health services company? Share your experience in the comments below.

InjuryClaims.com reports on litigation developments for informational purposes only. Nothing in this article constitutes legal advice. Eligibility for any settlement or lawsuit is determined by attorneys and courts, not by this publication.